2023
Treatment of Stiff-Person Syndrome with Botulinum Toxin
Safarpour D, Jabbari B. Treatment of Stiff-Person Syndrome with Botulinum Toxin. 2023, 174-179. DOI: 10.1017/9781009105033.021.Peer-Reviewed Original ResearchBotulinum toxinStiff-person syndromeBotulinum toxin therapyToxin therapyToxin formulationsBedside guidanceInjection siteCosmetic treatmentCadaveric dissectionAnatomical landmarksSmile correctionToxinTreatmentEyesInjectionClinician's eyeLower FacePathophysiologySyndromeTherapyCliniciansPhysiciansDissectionTreatment of Plantar Fasciitis/Plantar Fasciopathy with Botulinum Neurotoxins
Safarpour D, Mittal S, Jabbari B. Treatment of Plantar Fasciitis/Plantar Fasciopathy with Botulinum Neurotoxins. 2023, 269-274. DOI: 10.1017/9781009105033.034.Peer-Reviewed Original ResearchBotulinum toxinBotulinum toxin therapyPlantar FasciopathyToxin therapyToxin formulationsBedside guidanceInjection siteCosmetic treatmentCadaveric dissectionAnatomical landmarksSmile correctionBotulinum neurotoxinToxinTreatmentEyesInjectionClinician's eyeLower FacePathophysiologyTherapyCliniciansPhysiciansDissectionAirway compromise following contrast extravasation from an external jugular intravenous line
McDonald J, Schmitz J, Mendes B, McDonald R. Airway compromise following contrast extravasation from an external jugular intravenous line. Radiology Case Reports 2023, 19: 58-61. PMID: 37886022, PMCID: PMC10598708, DOI: 10.1016/j.radcr.2023.09.078.Peer-Reviewed Original ResearchContrast extravasationIodinated Contrast MaterialAirway compromiseCase of airway compromiseRisk of contrast extravasationAlternative injection sitesVascular access siteComputed tomography examsRare caseContrast materialIncreased riskAntecubital fossaIntravenous injectionVascular accessIntravenous lineExtravasationInjection siteAccess siteComplicationsAdditional careIV lineInjection
2022
PMON57 Impact of Injection Modalities on Real-World Injection Experience in Patients with Acromegaly or Neuroendocrine Tumors (NETs) Treated With Somatostatin Analog (SSA) Therapy: Data from the PRESTO 2 Survey
Ribeiro-Oliveira A, O’toole D, Kunz P, Houchard A, Boiziau S, Prebtani A, Webb S. PMON57 Impact of Injection Modalities on Real-World Injection Experience in Patients with Acromegaly or Neuroendocrine Tumors (NETs) Treated With Somatostatin Analog (SSA) Therapy: Data from the PRESTO 2 Survey. Journal Of The Endocrine Society 2022, 6: a557-a557. PMCID: PMC9625390, DOI: 10.1210/jendso/bvac150.1157.Peer-Reviewed Original ResearchInjection site painNeuroendocrine tumorsInjection experiencePrimary endpointLast doseLast injectionLanreotide autogel/depotFirst-line medical treatmentInjection modalitiesMultivariate logistic regression analysisOdds of painProportion of patientsSomatostatin analogue therapyInjection site reactionsLogistic regression analysisSecondary endpointsAnalogue therapySSA therapyDisease groupPainMedical treatmentPatientsAcromegalyInjection siteEndpointFever, Hypotension, and a Worsening Necrotic Wound
Peterson DM, Damsky WE, Vesely MD. Fever, Hypotension, and a Worsening Necrotic Wound. JAMA 2022, 327: 1496-1497. PMID: 35311923, DOI: 10.1001/jama.2022.2806.Peer-Reviewed Case Reports and Technical NotesSodium Tetradecyl Sulphate Sclerotherapy for Lateral Malleolar Bursitis of the Ankle
Yoon Y, Park J, Kim J, Han S, Shin S, Lee J, Park K. Sodium Tetradecyl Sulphate Sclerotherapy for Lateral Malleolar Bursitis of the Ankle. Clinics In Orthopedic Surgery 2022, 14: 289-296. PMID: 35685968, PMCID: PMC9152902, DOI: 10.4055/cios21182.Peer-Reviewed Original ResearchConceptsLateral malleolar bursitisSodium tetradecyl sulphateSF-36 physical component scoreSF-36Bursal sacEvaluate clinical outcomesResponse to treatmentAspiration of fluidSoft tissue swellingPhysical component scoreComplete responsePartial responseConsecutive patientsTransient hyperpigmentationConservative treatmentClinical outcomesShort Form SurveyFollow-upSclerotherapySide effectsPatientsInjection siteTetradecyl sulphateSoft tissueBursitis
2020
Feasibility and Efficacy of Pulsed-Dose Oxygen Delivery During Noninvasive Ventilation
Li L, Yang H, Jin H, Dai B, Peng Y, Tan W. Feasibility and Efficacy of Pulsed-Dose Oxygen Delivery During Noninvasive Ventilation. Respiratory Care 2020, 65: 1323-1332. PMID: 32753530, DOI: 10.4187/respcare.06922.Peer-Reviewed Original ResearchConceptsMode of oxygen deliveryOxygen injection siteNoninvasive ventilationOxygen deliveryClinical studiesInjection sitePulse oxygen saturationBench studyClinical parametersNo significant differenceSimulated lungCOPD exacerbationsOxygen saturationBreathing frequencySignificant differenceBreathing cycleDelivery modeEfficacyVentilationLungDeliveryBreathingExacerbation
2019
Concentration-dependent Toxicity after Subcutaneous Administration of Meloxicam to C57BL/6N Mice (Mus musculus).
Sarfaty AE, Zeiss CJ, Willis AD, Harris JM, Smith PC. Concentration-dependent Toxicity after Subcutaneous Administration of Meloxicam to C57BL/6N Mice (Mus musculus). Journal Of The American Association For Laboratory Animal Science 2019, 58: 802-809. PMID: 31540585, PMCID: PMC6926403, DOI: 10.30802/aalas-jaalas-19-000037.Peer-Reviewed Original ResearchConceptsInjection siteFull-thickness epidermal necrosisPost-operative analgesiaFemale C57BL/6N miceMouse Grimace ScaleYoung adult malesNSAID dosesGastrointestinal ulcerationCavitary lesionsC57BL/6N miceEpidermal necrosisKidney lesionsNSAID toxicityGastric ulcerationSaline controlsSubcutaneous administrationPathologic lesionsRelevant pathologyMinimal dosesLesionsSevere pathologySkin pathologyMiceSeventh dayMeloxicamEffect of Injection Site Cooling and Warming on Insulin Glargine Pharmacokinetics and Pharmacodynamics
Bitton G, Rom V, Hadelsberg U, Raz I, Cengiz E, Weinzimer S, Tamborlane WV. Effect of Injection Site Cooling and Warming on Insulin Glargine Pharmacokinetics and Pharmacodynamics. Journal Of Diabetes Science And Technology 2019, 13: 1123-1128. PMID: 31067999, PMCID: PMC6835184, DOI: 10.1177/1932296819842151.Peer-Reviewed Original ResearchConceptsInjection siteGlucose levelsSerum glucoseSubcutaneous depotMultiple daily insulin injectionsOvernight glucose levelsDaily insulin injectionsBlood glucose controlType 1 diabetesSensor glucose levelsInsulin infusion rateDL increaseInsulin glargineSerum insulinGlucose controlMDI therapyInsulin injectionsInsulin concentrationsPharmacodynamic studiesInfusion rateSkin warmingSeparate daysControl dayRate of absorptionRandom order
2015
Improved Postprandial Glucose Control Using the InsuPad Device in Insulin-Treated Type 2 Diabetes
Raz I, Bitton G, Feldman D, Alon T, Pfutzner A, Tamborlane WV. Improved Postprandial Glucose Control Using the InsuPad Device in Insulin-Treated Type 2 Diabetes. Journal Of Diabetes Science And Technology 2015, 9: 639-643. PMID: 25883166, PMCID: PMC4604546, DOI: 10.1177/1932296815578881.Peer-Reviewed Original ResearchConceptsRapid-acting insulin analoguesType 2 diabetesMeal tolerance testPlasma insulin levelsInsulin analoguesInsulin levelsGlucose excursionsInjection siteInsulin absorptionType 2 diabetic patientsPostmeal glucose excursionsStandardized liquid mealPostprandial glucose excursionsTime-action profilePostprandial glucose controlInsulin therapyDiabetic patientsGlucose controlLiquid mealOvernight fastInsulin aspartTolerance testPostprandial hyperglycemiaPremeal bolusesPremeal injections
2013
Oxygen Injection Site Affects FIO2 During Noninvasive Ventilation
Dai B, Kang J, Yu N, Tan W, Zhao H. Oxygen Injection Site Affects FIO2 During Noninvasive Ventilation. Respiratory Care 2013, 58: 1630-1636. PMID: 23533295, DOI: 10.4187/respcare.02172.Peer-Reviewed Original Research
2012
18F-FDG Cell Labeling May Underestimate Transplanted Cell Homing: More Accurate, Efficient, and Stable Cell Labeling with Hexadecyl-4-[18F]Fluorobenzoate for in Vivo Tracking of Transplanted Human Progenitor Cells by Positron Emission Tomography
Zhang Y, Dasilva JN, Hadizad T, Thorn S, Kuraitis D, Renaud JM, Ahmadi A, Kordos M, Dekemp RA, Beanlands RS, Suuronen EJ, Ruel M. 18F-FDG Cell Labeling May Underestimate Transplanted Cell Homing: More Accurate, Efficient, and Stable Cell Labeling with Hexadecyl-4-[18F]Fluorobenzoate for in Vivo Tracking of Transplanted Human Progenitor Cells by Positron Emission Tomography. Cell Transplantation 2012, 21: 1821-1835. PMID: 22469629, DOI: 10.3727/096368911x637416.Peer-Reviewed Original ResearchConceptsCirculating Progenitor CellsPositron emission tomographyEmission tomographyCell therapyPET imagingCell transplantation groupProgenitor cellsCoronary artery ligationRat myocardial infarction modelInfarct border zoneHeart tissue sectionsMyocardial infarction modelBorder zoneCardiac cell therapyTransplantation groupIschemic/Artery ligationH posttransplantationBest modalityHuman progenitor cellsIntramyocardial injectionH postinjectionInjection siteTissue biodistributionInfarction model
2009
Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users
Grau LE, Green TC, Singer M, Bluthenthal RN, Marshall PA, Heimer R. Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users. Harm Reduction Journal 2009, 6: 36. PMID: 20003518, PMCID: PMC2804675, DOI: 10.1186/1477-7517-6-36.Peer-Reviewed Original ResearchRisk reduction materialsSyringe exchange programsInjection drug usersHygiene suppliesDrug usersHealth promotion behaviorsAppropriate useHealth promotion materialsSEP clientsPrevention interventionsHepatitis riskBlood flowInjection practicesPromotion behaviorsInjection siteBrief interventionIntervention effectivenessIntervention packetInterventionPassive introductionPromotion materialsExchange programsOne-quarterSubstantial numberVerbal reminders
2007
Treatment of chronic low back pain with botulinum neurotoxins
Jabbari B. Treatment of chronic low back pain with botulinum neurotoxins. Current Pain And Headache Reports 2007, 11: 352-358. PMID: 17894925, DOI: 10.1007/s11916-007-0217-1.Peer-Reviewed Original ResearchConceptsLow back painChronic low back painBack painParaspinal musclesRefractory chronic low back painRefractory low back painFlu-like reactionsSignificant pain reliefOpen-label studyPlacebo-controlled studyBotulinum toxin ALumbar erector spinaeBotulinum treatmentPain reliefTechniques of treatmentLumbar levelsToxin AErector spinaePainSide effectsTrigger pointsInjection siteTotal dosePatientsEarly response
2006
Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: Insight into mechanisms?
Daskivich T, Oh W. Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: Insight into mechanisms? Urology 2006, 67: 1084.e15-1084.e17. PMID: 16698377, DOI: 10.1016/j.urology.2005.11.015.Peer-Reviewed Original ResearchMeSH KeywordsAbscessAdenocarcinomaAgedAndrogen AntagonistsAnilidesAntineoplastic Agents, HormonalBone NeoplasmsDelayed-Action PreparationsGonadotropin-Releasing HormoneGoserelinHumansLeuprolideMaleNitrilesOrchiectomyProstate-Specific AntigenProstatic NeoplasmsTestosteroneTosyl CompoundsTreatment FailureConceptsGonadotropin-releasing hormone agonistTestosterone suppressionHormone agonistSterile abscessGonadotropin-releasing hormone agonist therapyInjection siteAdvanced prostate cancerEvidence of inflammationSterile abscess formationDepot goserelinDepot leuprolideAgonist therapyProstate cancerAbscess formationPatientsTestosteroneAbscessAgonistsInjectionDepotGoserelinLeuprolideTherapySuppressionInflammation
2005
Psychosocial and Behavioral Differences Among Drug Injectors who Use and do not Use Syringe Exchange Programs
Grau LE, Bluthenthal RN, Marshall P, Singer M, Heimer R. Psychosocial and Behavioral Differences Among Drug Injectors who Use and do not Use Syringe Exchange Programs. AIDS And Behavior 2005, 9: 495-504. PMID: 16237501, DOI: 10.1007/s10461-005-9020-3.Peer-Reviewed Original ResearchConceptsSyringe exchange programsHIV risk characteristicsC virus infectionHIV prevention messagesOnly psychosocial factorHepatitis BObservational studyVirus infectionDrug injectorsPsychosocial factorsInjection sitePrevention messagesRisk profilePsychosocial characteristicsReported historyFuture interventionsStudy sampleIDUsExchange programsProgram effectivenessHIVRisk characteristicsInfection
2003
Safer Injection Sites in New York City: A Utilization Survey of Injection Drug Users
Broadhead R, Borch C, van Hulst Y, Farrell J, Villemez W, Altice F. Safer Injection Sites in New York City: A Utilization Survey of Injection Drug Users. Journal Of Drug Issues 2003, 33: 733-750. DOI: 10.1177/002204260303300311.Peer-Reviewed Original ResearchInjection drug usersSafe injection sitesDrug overdoseSample of IDUsDrug usersInjection siteDrug-related health problemsBlood-borne diseasesInnovative public health interventionsPublic health interventionsHarm Reduction ProjectHepatitis BDental servicesDrug treatmentPre-obtained drugsHigh riskHealth personnelHealth problemsHealth interventionsSignificant health riskSexual partnersNew York CityReferral servicesStreet outreachNew interventions
2002
Pelvic lymph node visualization with MR imaging using local administration of ultra‐small superparamagnetic iron oxide contrast
McCauley T, Rifkin M, Ledet C. Pelvic lymph node visualization with MR imaging using local administration of ultra‐small superparamagnetic iron oxide contrast. Journal Of Magnetic Resonance Imaging 2002, 15: 492-497. PMID: 11948841, DOI: 10.1002/jmri.10089.Peer-Reviewed Original ResearchConceptsPelvic lymph nodesMagnetic resonance imagingThigh injectionLymph nodesIron oxide particlesPeriprostatic injectionOxide particlesVisualized nodesPelvic lymphPeriprostatic tissueAnterior thighHealthy volunteersInjection siteResonance imagingInterstitial injectionMR imagingIron oxideGradient echo sequenceInjectionLocal administrationHigh fractionParticlesImagingLymphThigh
2001
Comparison of Intradermal and Subcutaneous Injections in Lymphatic Mapping
Kersey T, Van Eyk J, Lannin D, Chua A, Tafra L. Comparison of Intradermal and Subcutaneous Injections in Lymphatic Mapping. Journal Of Surgical Research 2001, 96: 255-259. PMID: 11266281, DOI: 10.1006/jsre.2000.6075.Peer-Reviewed Original ResearchConceptsLymph node basinSentinel nodesSC injectionInjection siteSlow transit timeNode basinLymphatic mappingBreast cancerInguinal lymph node basinsComparison of intradermalSame sentinel nodesIsosulfan blue dyeTechnetium sulfur colloidTransit timePeritumor injectionCervical lymphID injectionHigh success rateIntradermal injectionSubcutaneous injectionSulfur colloidDermal injectionClinical observationsCommon agentsSuccess rate
1999
Filtered Versus Unfiltered Technetium Sulfur Colloid in Lymphatic Mapping: A Significant Variable in a Pig Model
Tafra L, Chua A, Ng P, Aycock D, Swanson M, Lannin D. Filtered Versus Unfiltered Technetium Sulfur Colloid in Lymphatic Mapping: A Significant Variable in a Pig Model. Annals Of Surgical Oncology 1999, 6: 83-87. PMID: 10030419, DOI: 10.1007/s10434-999-0083-7.Peer-Reviewed Original ResearchConceptsUnfiltered groupLymphatic mappingSentinel nodesSkin sitesUnfiltered technetium sulfur colloidMore sentinel nodesSentinel node dissectionLymph node basinSentinel node biopsyFiltered groupIntraoperative lymphatic mappingTechnetium sulfur colloidSoft tissue tumorsStandard diagnostic testTc-99Node basinNode dissectionIsosulfan blueNode biopsyPreoperative lymphoscintigraphyLymph nodesSulfur colloidTissue tumorsGamma probeInjection site
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply